Skip to main content
. 2024 Sep 24;14(9):e088782. doi: 10.1136/bmjopen-2024-088782

Table 1. Dataset description; characteristics of PLHIV at their first visits since January 2018 from Geita and Kagera regions, Tanzania.

Clinic A Clinic B All sites (n=373)
Static variables N=9471 patients N=10 982 patients N=253 208 patients
Age in years (median, IQR) 36.3 (17.1) 35.0 (15.7) 35.6 (16.4)
Sex (%)
 Male 3253 (34.3%) 3606 (32.8%) 96 691 (38.2%)
 Female 6218 (65.7%) 7376 (67.2%) 156 517 (61.8%)
Time from HIV diagnosis to ART start, days (median, IQR) 724 (2086) 464 (1171) 392 (1053)
Time on ART, days (median, IQR) 757 (1887) 512 (1191) 464 (1086)
High viral load* (mean, SD) 0.6% (3.5%) 0.5% (2.5%) 0.5% (2.6%)
Disengagement (mean, SD) 6.0% (11.3%) 9.1% (11.6%) 7.3% (14.6%)
Dynamic variables N=165 353 visits N=177 482 visits N=4 255 537 visits
ART status (%)
 Not started ART 25 (0.02%) 27 (0.02%) 193 (0.005%)
 Start ART 6768 (4.1%) 6416 (3.6%) 170 296 (4.0%)
 Continue ART 151 959 (91.9%) 163 316 (92.0%) 3 909 752 (91.9%)
 Change ART 6563 (4.0%) 7694 (4.3%) 174 427 (4.1%)
 Restart ART 31 (0.02%) 4 (0.002%) 341 (0.008%)
 Stop ART 5 (0.003%) 4 (0.002%) 381 (0.009%)
 Missing values 2 (0.001%) 21 (0.01%) 147 (0.003%)

Not started ART: Entries where ART has not been initiated. Start ART: Entries documenting the initiation of ART. Continue ART: Entries where patients continue with their ART without changes. Change ART: Entries reflecting a switch in ART regimen/plan. Restart ART: Entries for patients resuming ART after a previous discontinuation. Stop ART: Entries documenting the stop of ART. Missing values: Entries where the ART status is not recorded or is unknown.

*

High viral load: percentage of instances where patients recorded a high viral load among all their visits.

Disengagement: the proportion of instances in which patients were recorded as disengaged from ART among all their visits. .

ART status: the percentage distribution of recorded ART (antiretroviral therapy) statuses, reflecting changes or continuities in ART.

ART, antiretroviral therapyPLHIVpeople living with HIV